Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
America Movil SAB de CV (NYSE: AMX) shares declined 1.61 percent to close at $20.12 a share Thursday. The stock traded between $19.89 and $20.26 on volume of 6.87 million shares traded. Analysts at Barclays have recently downgraded the company’s rating to "underweight" from "equal weight". Shares of America Movil have fallen approximately 14.0 percent year-to-date.
Find out more about America Movil including full access to the free equity report at:
www.RDInvesting.com/AMX
Booz Allen Hamilton Holding Corp. (NYSE: BAH) shares gained 2.33 percent to close at $19.79 a share Thursday. The stock traded between $19.54 and $20.15 on volume of 1.37 million shares traded. Analysts at JPMorgan have recently initiated coverage on the company with an "overweight" rating and a price target of $23.00. Shares of Booz Allen Hamilton have gained approximately 3.3 percent year-to-date.
Find out more about Booz Allen Hamilton including full access to the free equity report at:
www.RDInvesting.com/BAH
Terex Corporation (NYSE: TEX) shares gained 2.61 percent to close at $43.25 a share Thursday. The stock traded between $41.67 and $43.61 on volume of 2.35 million shares traded. Analysts at Stifel have recently downgraded the company’s rating to "neutral" from "buy". Shares of Terex have fallen approximately 3.0 percent year-to-date.
Find out more about Terex including full access to the free equity report at:
www.RDInvesting.com/TEX
Thoratec Corporation (NASDAQ: THOR) shares increased 2.10 percent to close at $36.45 a share Thursday. The stock traded between $35.90 and $36.67 on volume of 673,175 shares traded. Analysts at BTIG have recently initiated coverage on the company with a "buy" rating and a price target of $42.00. Shares of Thoratec have fallen approximately 0.40 percent year-to-date.
Find out more about Thoratec including full access to the free equity report at:
www.RDInvesting.com/THOR
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
[email protected]